La Prensa Medica.ISSN: 0032-745X

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Prensa Med Argent Vol: 101 Issue: 4

Implantable Port-a-Cath System Insertion in Patients with Metastatic Colon Cancer Receiving Bevacizumab-Based Chemotherapy

Abstract

 Implantable Port-a-Cath System Insertion in Patients with Metastatic Colon Cancer Receiving Bevacizumab-Based Chemotherapy

Combination of bevacizumab with continuous 5- fluoracil (5-FU)-based regimens are considered to be the backbone of colorectal cancer (CRC) systemic therapy. Administration of these continuous intravenous regimens requires insertion of an indwelling central venous catheters and implantable port systems. Certain aspects of the toxicity profile of Bevacizumab could interfere with implantable port-a-cath insertion. The aim of present study was to evaluate the safety port-a-cath insertion shortly before or during bevacizumab treatment in patients with metastatic colon cancer.

Keywords: Metastatic colon cancer; Port-a-cath; Implantable venous access catheter; Bevacizumab; Wound healing

Track Your Manuscript

H5 Index

SCImago Journal & Country Rank

Recommended Conferences

Share This Page